Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Search

Page Path
HOME > Search
2 "Byung Soo Kong"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Article
Basic and Translational Research
Article image
Anti-Senescence Effect of Inhibiting Sodium-Glucose Cotransporter 2 and α-Glucosidase in a Type 2 Diabetes Mellitus Animal Model
Serin Hong, Byung Soo Kong, Hyunsuk Lee, Young Min Cho
Diabetes Metab J. 2025;49(6):1229-1241.   Published online May 22, 2025
DOI: https://doi.org/10.4093/dmj.2024.0339
  • 5,151 View
  • 175 Download
  • 1 Web of Science
  • 1 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
The prevalence of type 2 diabetes mellitus (T2DM) increases with age, and cellular senescence of pancreatic β-cells plays a key role in T2DM pathogenesis. As canagliflozin and acarbose have been shown to increase lifespan in mice, we investigated the effect of sodium-glucose cotransporter 2 (SGLT2) inhibitor, α-glucosidase inhibitor or both on the cellular senescence of β-cells in a T2DM mouse model.
Methods
Enavogliflozin (0.3 mg/kg), acarbose (10 mg/kg), or vehicle was orally administered daily to db/db mice for 6 weeks. The levels of senescence markers (p16, p21, and p53) in the pancreas and kidney were measured through real-time polymerase chain reaction (PCR), immunofluorescence staining, and Western blot. In an in vitro analysis, isolated pancreatic islets were exposed to H2O2 to induce cellular senescence, then treated with β-hydroxybutyrate (β-HB), and subsequently assessed for levels of senescent markers.
Results
Enavogliflozin alone or combined with acarbose effectively lowered blood glucose levels in db/db mice. The combined treatment resulted in the greatest increase in β-cell function calculated using insulinogenic index and homeostasis model assessment of β-cell function compared to the vehicle. Additionally, the combined treatment significantly reversed the increase in p16, with a similar trend observed in p21 and p53 in the islets. Treatment increased circulating β-HB and in vitro analysis suggested the activation of nuclear factor erythroid 2-related factor 2 (Nrf2) by β-HB in reducing senescence in the islets.
Conclusion
The combined administration of enavogliflozin and acarbose significantly reduced blood glucose, improved β-cell function, and reduced senescent β-cells in db/db mice. This combination therapy holds potential as a senotherapeutic strategy for managing T2DM.

Citations

Citations to this article as recorded by  
  • Microneedle strategies for diabetic wound management: A comprehensive review of materials, mechanisms, and therapeutic outcomes
    Kaustubh Naik, Kanhaiya Singh
    Materials Today Advances.2026; 29: 100684.     CrossRef
Review
Basic Research
Article image
Mitochondrial-Encoded Peptide MOTS-c, Diabetes, and Aging-Related Diseases
Byung Soo Kong, Changhan Lee, Young Min Cho
Diabetes Metab J. 2023;47(3):315-324.   Published online February 24, 2023
DOI: https://doi.org/10.4093/dmj.2022.0333
  • 77,880 View
  • 637 Download
  • 22 Web of Science
  • 19 Crossref
AbstractAbstract PDFPubReader   ePub   
Mitochondria are complex metabolic organelles with manifold pathophysiological implications in diabetes. Currently published mitochondrial-encoded peptides, which are expressed from the mitochondrial open reading frame of the 12S ribosomal RNA type-c (MOTS-c), 16S rRNA (humanin and short humanin like peptide 1-6 [SHLP1-6]), or small human mitochondrial open reading frame over serine tRNA (SHMOOSE) are associated with regulation of cellular metabolism and insulin action in age-related diseases, such as type 2 diabetes mellitus. This review focuses mainly on recent advances in MOTS-c research with regards to diabetes, including both type 1 and type 2. The emerging understanding of MOTS-c in diabetes may provide insight into the development of new therapies for diabetes and other age or senescence-related diseases.

Citations

Citations to this article as recorded by  
  • Mutton fat-processing enhances the anti-osteoporotic effect of Epimedium koreanum Nakai via regulating the metabolism-inflammation-bone axis
    Xinyang Du, Jingran Li, Shuai Qu, Hong Kan, Yingping Wang
    Journal of Ethnopharmacology.2027; 372: 122153.     CrossRef
  • Cross-regulatory mechanisms linking ferroptosis, epigenetics, and circadian rhythm to mitochondrial quality control in diabetic cardiomyopathy
    Xinxin Liu, Yingqi Ma, Xuefeng Wang, Xiaowen Zhang, Chen Shen, Youzhu Su, Xing Chang, Hao Zhou, Jian-Ping Liu
    Journal of Advanced Research.2026; 84: 937.     CrossRef
  • MOTS-c is associated with oxidative stress and arterial stiffness in peritoneal dialysis patients: a pilot study
    Michela Musolino, Athanasios Roumeliotis, Stefanos Roumeliotis, Mariateresa Zicarelli, Federico Ruosi, Marta Greco, Roberta Misiti, Daniela Patrizia Foti, Vasiliki Sgouropoulou, Gordana Kocic, Andrej Veljkovic, Ioannis E. Neofytou, Ioannis Alekos, Efthymi
    International Urology and Nephrology.2026;[Epub]     CrossRef
  • Immunometabolism crosstalk between regulatory T cells and glucose homeostasis of type 1 diabetes
    Masoume Nodehi, Ziba Veisi Malekshahi, Ramin Rahimnia, Javad Verdi, Nasim Vousooghi, Iman Seyhoun
    Clinical and Experimental Immunology.2026;[Epub]     CrossRef
  • Humanin reduces nucleus pulposus cells ferroptosis to alleviate intervertebral disc degeneration: An in vitro and in vivo study
    Daxue Zhu, Zhaoheng Wang, Yanhu Li, Shijie Chen, Xuewen Kang
    Journal of Orthopaedic Translation.2025; 50: 274.     CrossRef
  • Non‐canonical ORFs‐derived protein products in mitochondria: A multifaceted exploration of their functions in health and disease
    Ikram Ajala, Benoît Vanderperre
    Protein Science.2025;[Epub]     CrossRef
  • Tomatine Improves Glucose Metabolism and Mitochondrial Respiration in Insulin-Resistant Hepatocyte Cell Lines AML12 and HepG2 via an AMP-Activated Protein Kinase-Dependent Pathway
    Yu Geon Lee, Donghwan Kim
    Cells.2025; 14(5): 329.     CrossRef
  • Microproteins in Metabolism
    Caris A. Wadding-Lee, Catherine A. Makarewich
    Cells.2025; 14(12): 859.     CrossRef
  • MOTS-c mimics exercise to combat diabetic liver fibrosis by targeting Keap1-Nrf2-Smad2/3
    Feilong Chen, Zhiyu Li, Tutu Wang, Yu Fu, Lei Lyu, Chengyuan Xing, Shunchang Li, Li
    Scientific Reports.2025;[Epub]     CrossRef
  • Mitochondrial-Derived Peptides: Implication in the Therapy of Neurodegenerative Diseases
    Rahul Thakur, Aman Chauhan, Hardika Moudgil, Sukhpal Singh, Rooma Devi
    Molecular Neurobiology.2025; 62(12): 15871.     CrossRef
  • Characterization of the Avian Mitochondrial-Derived Peptide MOTS-c and Its Potential Role as a Metabolic Regulator
    Xin Shu, Jiying Liu, Bingjie Xu, Hui Wang, Li Liu, Xiaotong Zheng, Jianfei Chen
    Animals.2025; 15(15): 2230.     CrossRef
  • Mitochondrial Microproteins: Emerging Regulators in Neurodevelopment and Neurodegeneration
    Nada Borghol, Sozerko Yandiev, Julien Courchet
    BioEssays.2025;[Epub]     CrossRef
  • Mitochondrial-encoded peptide MOTS-c prevents pancreatic islet cell senescence to delay diabetes
    Byung Soo Kong, Hyunsuk Lee, Sehi L’Yi, Serin Hong, Young Min Cho
    Experimental & Molecular Medicine.2025; 57(8): 1861.     CrossRef
  • UPRmt-regulated mitokines: novel strategies for myocardial injury repair
    Weinan Gao, Jia Liu, Wenda Zhang, Bin Liu, Luyan Shen
    Frontiers in Cell and Developmental Biology.2025;[Epub]     CrossRef
  • Mitochondrial-derived peptides: Antidiabetic functions and evolutionary perspectives
    Satadeepa Kal, Sumana Mahata, Suborno Jati, Sushil K. Mahata
    Peptides.2024; 172: 171147.     CrossRef
  • Mitochondrial Stress and Mitokines: Therapeutic Perspectives for the Treatment of Metabolic Diseases
    Benyuan Zhang, Joon Young Chang, Min Hee Lee, Sang-Hyeon Ju, Hyon-Seung Yi, Minho Shong
    Diabetes & Metabolism Journal.2024; 48(1): 1.     CrossRef
  • Mitochondrial bioenergetics, metabolism, and beyond in pancreatic β-cells and diabetes
    Alejandra María Rivera Nieves, Brian Michael Wauford, Accalia Fu
    Frontiers in Molecular Biosciences.2024;[Epub]     CrossRef
  • Haplotype variability in mitochondrial rRNA predisposes to metabolic syndrome
    Petr Pecina, Kristýna Čunátová, Vilma Kaplanová, Guillermo Puertas-Frias, Jan Šilhavý, Kateřina Tauchmannová, Marek Vrbacký, Tomáš Čajka, Ondřej Gahura, Markéta Hlaváčková, Viktor Stránecký, Stanislav Kmoch, Michal Pravenec, Josef Houštěk, Tomáš Mráček, A
    Communications Biology.2024;[Epub]     CrossRef
  • Pyrroloquinoline Quinone Alleviates Mitochondria Damage in Radiation-Induced Lung Injury in a MOTS-c-Dependent Manner
    Yanli Zhang, Jianfeng Huang, Shengpeng Li, Junlin Jiang, Jiaojiao Sun, Dan Chen, Qingfeng Pang, Yaxian Wu
    Journal of Agricultural and Food Chemistry.2024; 72(38): 20944.     CrossRef

Diabetes Metab J : Diabetes & Metabolism Journal
Close layer
TOP